Actionable news
All posts from Actionable news
Actionable news in ICPT: Intercept Pharmaceuticals, Inc.,

Trade-Ideas: Intercept Pharmaceuticals (ICPT) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Intercept Pharmaceuticals ( ICPT) as a post-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Intercept Pharmaceuticals as such a stock due to the following factors:

  • ICPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $93.1 million.
  • ICPT is up 2.6% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICPT with the Ticky from Trade-Ideas. See the FREE profile for ICPT NOW at Trade-Ideas More details on ICPT: Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Currently there are 7 analysts that rate Intercept Pharmaceuticals a buy, 2 analysts rate it a sell, and 2 rate it a hold. The average volume for Intercept Pharmaceuticals has been 588,000 shares per day over the past 30 days. Intercept has a market cap of $3.6 billion and is part of the health care sector and drugs industry. The stock has a beta of -2.45 and a short float of 35.5% with 6.29 days to cover. Shares are up 3.9% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER:...